Anti-CD4 monoclonal antibody administration in renal transplanted patients
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 56 (3) , 311-322
- https://doi.org/10.1016/0090-1229(90)90152-g
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Immunotherapy of the Nonobese Diabetic Mouse: Treatment with an Antibody to T-Helper LymphocytesScience, 1988
- THE EFFECT OF ANTI-L3T4 MONOCLONAL ANTIBODY TREATMENT ON FIRST-SET REJECTION OF MURINE CARDIAC ALLOGRAFTSTransplantation, 1987
- MONOCLONAL ANTI-CD4 IN ARTHRITISThe Lancet, 1987
- Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD miceDiabetes, 1987
- SKIN ALLOGRAFT REJECTION BY L3/t4+ AND LYT-2+ T CELL SUBESTSTransplantation, 1986
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.The Journal of Experimental Medicine, 1985
- Reversal of Experimental Allergic Encephalomyelitis with Monoclonal Antibody to a T-Cell Subset MarkerScience, 1985
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- EFFECTS OF IN VIVO ADMINISTRATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR HUMAN T CELL SUBPOPULATIONS ON THE IMMUNE SYSTEM IN A RHESUS MONKEY MODELTransplantation, 1983